LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Publisher: BioMed Central
Journal: Malaria Journal
Languages: English
Types: Article
Subjects: Arctic medicine. Tropical medicine, qx_135, DOAJ:Health Sciences, Internal medicine, RC31-1245, qv_256, Review, DOAJ:Internal medicine, Infectious and parasitic diseases, wc_750, Medicine, wc_770, R, DOAJ:Medicine (General), wb_340, ws_200, RC955-962, RC109-216

Abstract

Background

In children with malaria caused by Plasmodium falciparum, quinine administered rectally may be easier to use and less painful than intramuscular or intravenous administration. The objective of this review was to compare the effectiveness of intrarectal with intravenous or intramuscular quinine for treating falciparum malaria.

Methods

All randomized and quasi-randomized controlled trials comparing intrarectal with intramuscular or intravenous quinine for treating people with falciparum malaria located through the following sources were included: Cochrane Infectious Diseases Group Specialized Register, CENTRAL, MEDLINE, EMBASE, LILACS and CINAHL. Trial quality was assessed and data, including adverse event data, were extracted. Dichotomous data were analysed using odds ratios and continuous data using weighted mean difference.

Results

Eight randomized controlled trials (1,247 children) fulfilled the inclusion criteria. The same principal investigator led seven of the trials. Five compared intrarectal with intravenous quinine, and six compared intrarectal with intramuscular treatment. No statistically significant difference was detected for death, parasite clearance by 48 hours and seven days, parasite and fever clearance time, coma recovery time, duration of hospitalization and time before drinking began. One trial (898 children) reported that intrarectal was less painful than intramuscular administration.

Conclusion

No difference in the effect on parasites and clinical illness was detected for the use of intrarectal quinine compared with other routes, but most trials were small. Pain during application may be less with intrarectal quinine. Further larger trials, in patients with severe malaria and in adults, are required before the intrarectal route could be recommended.

  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • Greenwood B, Marsh K, Snow R: Why do some African children develop severe malaria? Parasitol Today 1991, 7:277-281.
    • Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster. Trans R Soc Trop Med Hyg 2000, 94(Suppl 1):S1-S90.
    • Anothay O, Pongvongsa T, Maharat N, Sirivichayakul C, Chantavanich P, Silachamroon U, Looareesuwan S: Clinical presentation of childhood malaria in Savannakhet province, Lao PDR. Southeast Asian J Trop Med Public Health 2000, 31(Suppl 1):85-90.
    • Kortepeter M, Brown JD: A review of 79 patients with malaria seen at a military hospital in Hawaii from 1979-95. Mil Med 1998, 163:84-89.
    • Piarroux R, Dumon H, Garnier JM, Lehmann M, Unal D, Quilici M: Choice of therapy for imported cases of falciparum malaria in children: a retrospective study of 100 cases seen in Marseilles, France. Trans R Soc Trop Med Hyg 1993, 87:72-74.
    • 6. Sowunmi A, Ogundahunsi OA, Falade CO, Gbotosho GO, Oduola AM: Gastrointestinal manifestations of acute falciparum malaria in children. Acta Trop 2000, 74:73-76.
    • 7. White NJ, Looreesuwan S, Warrell DA, Warrell MJ, Bunnag D, Harinasuta T: Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria. Am J Med 1982, 73:564-572.
    • 8. Bjorkman A: Quinine-resistant malaria in Africa. Trans R Soc Trop Med Hyg 1991, 85:138-139.
    • 9. Jelinek T, Schelbert P, Loescher T, Eichenlaub D: Quinine resistant falciparum malaria acquired in East Africa. Trop Med Parasitol 1995, 46:38-40.
    • 10. Global Partnership to Roll Back Malaria. The use of antimalarial drugs: report of a WHO informal consultation, 13-17 November 2000. Geneva: World Health Organization; 2001.
    • 11. Barennes H: Les injections intramusculaires chez l'enfant en Afrique subsaharienne, à propos d'une pathologie souvent méconnue: les complications liées aux injections intramusculaires de quinine. Bull Soc Pathol Exot 1999, 92:33-37.
    • 12. Barennes H, Renouil M, Macaigne F, Raoseta V, Raoeline Y: Efficacité de la quinine injectable diluée en intra-rectal dans le paludisme de l'enfant et excrétion urinaire de la quinine. Médecine d'Afrique Noire 1993, 40:401-404.
    • 13. Bourrel P, Souvestre R: Les lésions du nerf sciatique par injections intra-fessières de quinine. Med Trop 1982, 42:209-221.
    • 14. Carayon A, Blanc JF, Caron JJ: Accidents nerveux par infections intra-fessières d'antipaludiques. Indication de la neurolyse des troncs plexuels sciatiques. Bull Soc Méd Afr Noire Lang Franç 1960, 52:112-123.
    • 15. Yen LM, Dao LM, Day NP, Waller DJ, Bethell DB, Son LH, Hien TT, White NJ: Role of quinine in the high mortality of intramuscular injection tetanus. Lancet 1994, 344:786-787.
    • 16. Wyatt HV: Poliomyelitis in developing countries: lower limb paralysis and infections. Trans R Soc Trop Med Hyg 1989, 83:545-549.
    • 17. Wyatt HV, Mahadevan S, Srinivasan S: Unnecessary injections and paralytic poliomyelitis in India. Trans R Soc Trop Med Hyg 1992, 86:546-549.
    • 18. Hoelscher M, Riedner G, Hemed Y, Wagner H, Korte R, von Sonnenburg F: Estimating the number of HIV transmissions through reused syringes and needles in the Mbeya Region, Tanzania. AIDS 1994, 8:1609-1615.
    • 19. Wyatt HV: The popularity of injections in the Third World: origins and consequences for poliomyelitis. Soc Sci Med 1984, 19:911-915.
    • 20. Barennes H, Pussard E, Mahaman Sani A, Clavier F, Kahiatani F, Ganic G, Henzel D, Ravinet L, Verdier F: Efficacy and pharmacokinetics of a new intrarectal quinine formulation in children with Plasmodium falciparum malaria. Br J Clin Pharmacol 1996, 41:389-395.
    • 21. Barennes H, Mahaman Sani A, Kahia Tani F, Meda H, Khenine A: Tolérance de la quinine administrée en solution intrarectale chez l'enfant en Afrique Francophone. Med Trop 1999, 59:383-388.
    • 22. Eisenhut M, Omari AAA: Intrarectal quinine for treating Plasmodium falciparum malaria. The Cochrane Database of Systematic Reviews 2005. Art. No.: CD 004009. DOI: 10.1002/14651858/ CD004009.pub2
    • 23. Juni P, Altman DG, Egger M: Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001, 323:42-46.
    • 24. Barennes H, Kahiatani D, Pussard E, Clavier F, Meynard D, Njifountawouo S, Verdier F: Intrarectal Quinimax (an association of Cinchona alkaloids) for the treatment of Plasmodium falciparum malaria in children in Niger: efficacy and pharmacokinetics. Trans R Soc Trop Med Hyg 1995, 89:418-421.
    • 25. Barennes H, Munjakazi J, Verdier F, Clavier F, Pussard E: An open randomized clinical study of intrarectal versus infused Quinimax for the treatment of childhood cerebral malaria in Niger. Trans R Soc Trop Med Hyg 1998, 92:437-440.
    • 26. Barennes H, Sterlingot H, Nagot N, Meda H, Kabore M, Sanou M, Nacro B, Bouree P, Pussard E: Intrarectal pharmacokinetics of two formulations of quinine in children with falciparum malaria. Eur J Clin Pharmacol 2003, 58:649-652.
    • 27. Barennes H, Verdier F, Clavier F, Pussard E: Pharmacokinetics of Quinimax suppositories in children with malaria: a preliminary study. Clinical Drug Investigation 1999, 17:287-291.
    • 28. Assimadi JK, Gbadoe AD, Agbodjan-Djossou O, Larsen SE, Kusiaku K, Lawson-Evi K, Redah D, Adjogble A, Gayibor A: Quinine injectable diluée en intramusculaire et en intrarectal: efficacité et tolérance comparées dans le traitement du paludisme de l'enfant. Med Trop 2002, 62:158-162.
    • 29. Barennes H, Kailou D, Pussard E, Munjakazi JM, Fernan M, Sherouat H, Sanda A, Clavier F, Verdier F: Administration intrarectale de la quinine: un traitement précoce du paludisme grave de l'enfant? Santé 2001, 11:145-153.
    • 30. Barennes H: Intrarectal administration of Quinimax® in children: bioavailability, efficacy and tolerance. Symposium workbook, The Third MIM Pan-African Conference on Malaria, 17-22 November, Arusha, Tanzania 2002:16-23.
  • No related research data.
  • No similar publications.

Share - Bookmark

Cite this article